NextCure, Inc. (NXTC) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2024 | $474.0K | -42.2% |
| 2023 | $820.0K | -61.2% |
| 2022 | $2.12M | -10.3% |
| 2021 | $2.36M | -66.9% |
| 2020 | $7.13M | +111.6% |
| 2019 | $3.37M | +10.1% |
| 2018 | $3.06M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2024 | $474.0K | -42.2% |
| 2023 | $820.0K | -61.2% |
| 2022 | $2.12M | -10.3% |
| 2021 | $2.36M | -66.9% |
| 2020 | $7.13M | +111.6% |
| 2019 | $3.37M | +10.1% |
| 2018 | $3.06M | — |